Elucidating the molecular drivers underlying schizophrenia

Identifying the disrupted molecular changes that underlie mental illnesses like schizophrenia remains a challenge for the development of novel effective treatments.

This project will use molecular techniques to examine gene and protein changes in brain tissue from preclinical animal models and clinical postmortem samples, working in collaboration with Professor Brian Dean.